TB-500 (10mg)

Manufactured in the USA by a Licensed Pharmaceutical Facility
Veteran Operated Company

TB-500 is a synthetic peptide derived from the naturally occurring protein thymosin beta-4 and is commonly used in research focused on cytoskeletal dynamics, cellular mobility, and regeneration-related signaling. Scientific studies frequently examine TB-500 for its involvement in actin-binding pathways, which play a central role in cell migration, tissue formation, and structural remodeling processes. Because of its predictable biochemical activity, TB-500 is a valuable tool for mapping cellular behavior in laboratory-controlled regeneration models.

Researchers also use TB-500 in studies involving angiogenesis signaling and fibroblast-driven tissue modeling, where its structural properties support reproducible observation of cellular responses. Its stability, purity, and receptor-independent mechanism make it well suited for a wide range of regenerative and cell-migration research applications.

All Nova9 TB-500 is manufactured in a licensed U.S. pharmaceutical facility and verified at ≥99% purity, ensuring consistent performance and high structural integrity across batch cycles. Supplied as a lyophilized peptide, it is engineered for precision-driven scientific environments requiring dependable peptide composition.

Made in the USA by a Licensed Pharmaceutical Facility
Veteran Operated Company

For Research Use Only. Not for human consumption, not for veterinary use, and not for diagnostic or therapeutic purposes. All customers certify these materials will be used solely in controlled laboratory environments.